Gonadotropin-releasing hormone signaling pathways in an experimental ovarian tumor

Previous results showed that GnRH signaling is altered in cells from rat luteinized ovarian tumors (tumor group) because it did not activate the phospholipase C pathway, in contrast to control ovarian cells from superovulated prepubertal rats (SPO). In the present work, alternate GnRH-induced second...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2003
Materias:
rat
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00137227_v144_n7_p2957_ChamsonReig
http://hdl.handle.net/20.500.12110/paper_00137227_v144_n7_p2957_ChamsonReig
Aporte de:
id paper:paper_00137227_v144_n7_p2957_ChamsonReig
record_format dspace
spelling paper:paper_00137227_v144_n7_p2957_ChamsonReig2023-06-08T14:36:11Z Gonadotropin-releasing hormone signaling pathways in an experimental ovarian tumor 2 [1 (3 dimethylaminopropyl) 3 indolyl] 3 (3 indolyl)maleimide 9 (tetrahydro 2 furyl)adenine arachidonic acid buserelin cyclic AMP gonadorelin gonadorelin agonist guanine nucleotide binding protein mitogen activated protein kinase mitogen activated protein kinase 1 phospholipase A2 phospholipase C phospholipase D progesterone animal cell animal experiment animal model article cell type controlled study enzyme activation female nonhuman ovary tumor prepuberty priority journal protein phosphorylation rat superovulation Adenylate Cyclase Animals Antineoplastic Agents, Hormonal Buserelin Carcinogens Cyclic AMP Enzyme Activation Female Gonadotropin-Releasing Hormone GTP-Binding Protein alpha Subunits GTP-Binding Protein alpha Subunits, Gi-Go Heterotrimeric GTP-Binding Proteins Luteoma Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinase 3 Mitogen-Activated Protein Kinases Ovarian Neoplasms Pertussis Toxin Phospholipase D Phospholipases A Phosphorylation Progesterone Protein Kinase C Rats Rats, Sprague-Dawley Signal Transduction Tetradecanoylphorbol Acetate Tumor Cells, Cultured Previous results showed that GnRH signaling is altered in cells from rat luteinized ovarian tumors (tumor group) because it did not activate the phospholipase C pathway, in contrast to control ovarian cells from superovulated prepubertal rats (SPO). In the present work, alternate GnRH-induced second messengers such as phospholipase A2 and phospholipase D activation, cAMP production, ERK1/2 phosphorylation, and the presence of G proteins were evaluated to determine GnRH mechanism of action in tumor cells. G proteins examined were present in both cell types. Buserelin, a GnRH agonist, (1, 10, and 100 ng/ml) increased phosphatidylethanol in SPO, indicating phospholipase D activation. Only 100 ng/ml buserelin induced a significant response in the tumor group. Buserelin (100 ng/ml) increased 3H-arachidonic acid in culture media in SPO, indicating phospholipase A2 activation; no effect was observed in the tumor group. Buserelin (100 and 1000 ng/ml) induced pertussis toxin-insensitive cAMP increases in both cell types, with similar potencies. In the tumor group, buserelin (100 ng/ml) inhibited human chorionic gonadotropin-induced cAMP and progesterone; this effect was protein kinase C (PKC) dependent (inhibited by GF109203X, a PKC inhibitor). Buserelin (100 and 1000 ng/ml) induced ERK1/2 phosphorylation in both cell kinds. Buserelin-induced ERK1/2 activation was Gi/0 independent and PKC dependent. Only in the tumor group, buserelin-induced ERK1/2 activation was cAMP dependent (abolished by SQ 22536, the adenylyl cyclase inhibitor). Furthermore, dibutyryl cAMP-induced ERK1/2 activation in the tumor group was PKC dependent (inhibited by GF109203X). In conclusion, activation of phospholipases in tumor cells does not seem to mediate GnRH effects. GnRH signaling seems to involve adenylyl cyclase activation, PKC stimulation, and ERK1/2 phosphorylation. 2003 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00137227_v144_n7_p2957_ChamsonReig http://hdl.handle.net/20.500.12110/paper_00137227_v144_n7_p2957_ChamsonReig
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic 2 [1 (3 dimethylaminopropyl) 3 indolyl] 3 (3 indolyl)maleimide
9 (tetrahydro 2 furyl)adenine
arachidonic acid
buserelin
cyclic AMP
gonadorelin
gonadorelin agonist
guanine nucleotide binding protein
mitogen activated protein kinase
mitogen activated protein kinase 1
phospholipase A2
phospholipase C
phospholipase D
progesterone
animal cell
animal experiment
animal model
article
cell type
controlled study
enzyme activation
female
nonhuman
ovary tumor
prepuberty
priority journal
protein phosphorylation
rat
superovulation
Adenylate Cyclase
Animals
Antineoplastic Agents, Hormonal
Buserelin
Carcinogens
Cyclic AMP
Enzyme Activation
Female
Gonadotropin-Releasing Hormone
GTP-Binding Protein alpha Subunits
GTP-Binding Protein alpha Subunits, Gi-Go
Heterotrimeric GTP-Binding Proteins
Luteoma
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinases
Ovarian Neoplasms
Pertussis Toxin
Phospholipase D
Phospholipases A
Phosphorylation
Progesterone
Protein Kinase C
Rats
Rats, Sprague-Dawley
Signal Transduction
Tetradecanoylphorbol Acetate
Tumor Cells, Cultured
spellingShingle 2 [1 (3 dimethylaminopropyl) 3 indolyl] 3 (3 indolyl)maleimide
9 (tetrahydro 2 furyl)adenine
arachidonic acid
buserelin
cyclic AMP
gonadorelin
gonadorelin agonist
guanine nucleotide binding protein
mitogen activated protein kinase
mitogen activated protein kinase 1
phospholipase A2
phospholipase C
phospholipase D
progesterone
animal cell
animal experiment
animal model
article
cell type
controlled study
enzyme activation
female
nonhuman
ovary tumor
prepuberty
priority journal
protein phosphorylation
rat
superovulation
Adenylate Cyclase
Animals
Antineoplastic Agents, Hormonal
Buserelin
Carcinogens
Cyclic AMP
Enzyme Activation
Female
Gonadotropin-Releasing Hormone
GTP-Binding Protein alpha Subunits
GTP-Binding Protein alpha Subunits, Gi-Go
Heterotrimeric GTP-Binding Proteins
Luteoma
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinases
Ovarian Neoplasms
Pertussis Toxin
Phospholipase D
Phospholipases A
Phosphorylation
Progesterone
Protein Kinase C
Rats
Rats, Sprague-Dawley
Signal Transduction
Tetradecanoylphorbol Acetate
Tumor Cells, Cultured
Gonadotropin-releasing hormone signaling pathways in an experimental ovarian tumor
topic_facet 2 [1 (3 dimethylaminopropyl) 3 indolyl] 3 (3 indolyl)maleimide
9 (tetrahydro 2 furyl)adenine
arachidonic acid
buserelin
cyclic AMP
gonadorelin
gonadorelin agonist
guanine nucleotide binding protein
mitogen activated protein kinase
mitogen activated protein kinase 1
phospholipase A2
phospholipase C
phospholipase D
progesterone
animal cell
animal experiment
animal model
article
cell type
controlled study
enzyme activation
female
nonhuman
ovary tumor
prepuberty
priority journal
protein phosphorylation
rat
superovulation
Adenylate Cyclase
Animals
Antineoplastic Agents, Hormonal
Buserelin
Carcinogens
Cyclic AMP
Enzyme Activation
Female
Gonadotropin-Releasing Hormone
GTP-Binding Protein alpha Subunits
GTP-Binding Protein alpha Subunits, Gi-Go
Heterotrimeric GTP-Binding Proteins
Luteoma
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinases
Ovarian Neoplasms
Pertussis Toxin
Phospholipase D
Phospholipases A
Phosphorylation
Progesterone
Protein Kinase C
Rats
Rats, Sprague-Dawley
Signal Transduction
Tetradecanoylphorbol Acetate
Tumor Cells, Cultured
description Previous results showed that GnRH signaling is altered in cells from rat luteinized ovarian tumors (tumor group) because it did not activate the phospholipase C pathway, in contrast to control ovarian cells from superovulated prepubertal rats (SPO). In the present work, alternate GnRH-induced second messengers such as phospholipase A2 and phospholipase D activation, cAMP production, ERK1/2 phosphorylation, and the presence of G proteins were evaluated to determine GnRH mechanism of action in tumor cells. G proteins examined were present in both cell types. Buserelin, a GnRH agonist, (1, 10, and 100 ng/ml) increased phosphatidylethanol in SPO, indicating phospholipase D activation. Only 100 ng/ml buserelin induced a significant response in the tumor group. Buserelin (100 ng/ml) increased 3H-arachidonic acid in culture media in SPO, indicating phospholipase A2 activation; no effect was observed in the tumor group. Buserelin (100 and 1000 ng/ml) induced pertussis toxin-insensitive cAMP increases in both cell types, with similar potencies. In the tumor group, buserelin (100 ng/ml) inhibited human chorionic gonadotropin-induced cAMP and progesterone; this effect was protein kinase C (PKC) dependent (inhibited by GF109203X, a PKC inhibitor). Buserelin (100 and 1000 ng/ml) induced ERK1/2 phosphorylation in both cell kinds. Buserelin-induced ERK1/2 activation was Gi/0 independent and PKC dependent. Only in the tumor group, buserelin-induced ERK1/2 activation was cAMP dependent (abolished by SQ 22536, the adenylyl cyclase inhibitor). Furthermore, dibutyryl cAMP-induced ERK1/2 activation in the tumor group was PKC dependent (inhibited by GF109203X). In conclusion, activation of phospholipases in tumor cells does not seem to mediate GnRH effects. GnRH signaling seems to involve adenylyl cyclase activation, PKC stimulation, and ERK1/2 phosphorylation.
title Gonadotropin-releasing hormone signaling pathways in an experimental ovarian tumor
title_short Gonadotropin-releasing hormone signaling pathways in an experimental ovarian tumor
title_full Gonadotropin-releasing hormone signaling pathways in an experimental ovarian tumor
title_fullStr Gonadotropin-releasing hormone signaling pathways in an experimental ovarian tumor
title_full_unstemmed Gonadotropin-releasing hormone signaling pathways in an experimental ovarian tumor
title_sort gonadotropin-releasing hormone signaling pathways in an experimental ovarian tumor
publishDate 2003
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00137227_v144_n7_p2957_ChamsonReig
http://hdl.handle.net/20.500.12110/paper_00137227_v144_n7_p2957_ChamsonReig
_version_ 1768544485169430528